Oral formulations of nicotine replacement therapies and cessation aids target tobacco dependence. Suppliers in the pharmaceutical sector distribute to addiction treatment centers, general practitioners, and retail outlets. Medical buyers procure them for patient support in smoking cessation programs across healthcare